Transition to Recombinant rFC for Endotoxin Testing: The Sustainable Choice

Tuesday, February 1, 2022
  • <<
  • >>

An endotoxin-sensitive enzyme found in horseshoe crab blood has been used to test Lipopolysaccharides in pharmaceutical products since 1983. To move to a more sustainable method for Lipopolysaccharides testing, a recombinant protein, Recombinant Horseshoe Crab Factor C (rFC), was developed. rFC provides a consistent, secure and environmentally sustainable method for endotoxin testing.

Mycoplasma Detection for Bioprocessing Applications

Download Now

    Please fill out the information below to download content. If you are already registered, or have requested a quote before, and this information will be filled out for you.
  • By submitting this form, you agree to receive email from American Pharmaceutical Review and from this Industry Expert Hub sponsor.